In this episode of Cannabis Unlocked, Mara Sheldon (Principal at Squire Patton Boggs) sits down with Tiby Erdely (Founding Partner at KEY Investment Partners) to discuss the recent U.S. Department of Health and Human Services (HHS) recommendation to the Department of Justice to reschedule cannabis from a Schedule 1 drug to Schedule 3. The conversation begins with Mara’s thoughts on HHS’ recommendation and what rescheduling could mean for the cannabis industry. 

From there, the conversation shifts to the positive and negative implications of a schedule 3 reclassification and the political pressure this recommendation creates. Please enjoy!